Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 451-460

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

By Wilop Stefan   Hobe Sabine   Crysandt Martina   Esser Albert   Osieka Rainhardt   Jost Edgar  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1429-1435

Springer Publishing Company

Access to resources Recommend Favorite

Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker

By Molteni A.   Moulder J. E.   Cohen E. F.   Ward W. F.   Fish B. L.   Taylor J. M.   Wolfe L. F.   Brizio-Molteni L.   Veno P.  

International Journal of Radiation Biology, Vol. 76, Iss. 4, 2000-04 ,pp. : 523-532

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy

By Blaes Anne  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 585-590

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2408-2414

Spandidos Publications

Access to resources Recommend Favorite